Ortigosa, L. C. (2013) “Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis”, Acta Dermato-Venereologica, 94(1), pp. 26–31. doi: 10.2340/00015555-1650.